Guardian Pharmacy Services, Inc.’s Quiet Period Will Expire on November 5th (NYSE:GRDN)

Guardian Pharmacy Services’ (NYSE:GRDN) quiet period will expire on Tuesday, November 5th. Guardian Pharmacy Services had issued 8,000,000 shares in its initial public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. During the company’s quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Truist Financial initiated coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They set a “buy” rating and a $22.00 target price on the stock. Raymond James began coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They set an “outperform” rating and a $21.00 price target for the company. Finally, Stephens began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 target price for the company.

Guardian Pharmacy Services Price Performance

Shares of GRDN stock opened at $18.64 on Tuesday. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $20.10.

Insider Transactions at Guardian Pharmacy Services

In related news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was bought at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the purchase, the director now directly owns 35,714 shares of the company’s stock, valued at approximately $499,996. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Hedge Funds Weigh In On Guardian Pharmacy Services

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Stephens Inc. AR purchased a new position in Guardian Pharmacy Services during the third quarter worth about $189,000. Seven Grand Managers LLC acquired a new stake in Guardian Pharmacy Services in the 3rd quarter valued at about $2,515,000. Finally, Allspring Global Investments Holdings LLC acquired a new position in Guardian Pharmacy Services during the third quarter worth about $5,460,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.